Results 301 to 310 of about 148,383 (342)
Some of the next articles are maybe not open access.
2017
Propranolol is a noncardioselective β-blocker. It is reported to have membrane-stabilizing properties, but it does not own intrinsic sympathomimetic activity. Propranolol hydrochloride is used to control hypertension, pheochromocytoma, myocardial infarction, cardiac arrhythmias, angina pectoris, and hypertrophic cardiomyopathy.
Hatem A. Abdel Aziz +4 more
openaire +3 more sources
Propranolol is a noncardioselective β-blocker. It is reported to have membrane-stabilizing properties, but it does not own intrinsic sympathomimetic activity. Propranolol hydrochloride is used to control hypertension, pheochromocytoma, myocardial infarction, cardiac arrhythmias, angina pectoris, and hypertrophic cardiomyopathy.
Hatem A. Abdel Aziz +4 more
openaire +3 more sources
Obstetrics & Gynecology, 1978
Propranolol is a beta-adrenergic blocking drug with a wide spectrum of use and may diverse pharmacologic effects. This case report is an example of a parturient who was on a large dose of propranolol for idiopathic hypertrophic subaortic stenosis. The effects of this drug on pregnancy, labor, and above all, the fetus are discussed.
Stephen C. Schoenbaum +3 more
openaire +3 more sources
Propranolol is a beta-adrenergic blocking drug with a wide spectrum of use and may diverse pharmacologic effects. This case report is an example of a parturient who was on a large dose of propranolol for idiopathic hypertrophic subaortic stenosis. The effects of this drug on pregnancy, labor, and above all, the fetus are discussed.
Stephen C. Schoenbaum +3 more
openaire +3 more sources
Radioimmunoassay of propranolol
Analytical Chemistry, 1983A series of specific antibodies against d,I-propranolol has been developed by conjugation of the novel 5'-, 7'-, and 8'-(3-aminopropoxy)propranolol derivatives to succinylated bovine serum albumin. By preservation of an intact side chain in the antigen, significantly improved specificity to parent drug vs.
Daniel R. Knapp +2 more
openaire +3 more sources
Pharmacokinetics of propranolol
Journal of Pharmacokinetics and Biopharmaceutics, 1981The pharmacokinetics of propranolol after the administration of 40, 80, and 120 mg p.o. and 10 mg i.v. was studied in nine healthy male volunteers. Propranolol was analyzed after extraction and derivatization by gas-liquid chromatography. A multiexponential curve-stripping program was used for the pharmacokinetic analysis.
Lars Borgström +3 more
openaire +3 more sources
Journal of Pharmaceutical Sciences, 1979
Two improvements in propranolol resolution were developed. Both the (+)- and (-)-di-(p-toluoyl)tartaric acids were used as the resolving agents. This procedure reduced the number of crystallizations needed to obtain a pure product. Furthermore, synthesis of the resolving agent was improved.
Yul Yost +2 more
openaire +3 more sources
Two improvements in propranolol resolution were developed. Both the (+)- and (-)-di-(p-toluoyl)tartaric acids were used as the resolving agents. This procedure reduced the number of crystallizations needed to obtain a pure product. Furthermore, synthesis of the resolving agent was improved.
Yul Yost +2 more
openaire +3 more sources
American Journal of Psychiatry, 1982
The authors report the cases of 3 patients who had depressive episodes after administration of propranolol for medical illnesses. The depressive episodes were severe, occurred in a dose-dependent manner, and promptly remitted when propranolol was discontinued. Physicians' awareness of this complication, especially in cases of patients with a history of
Raymond L. Woosley +2 more
openaire +3 more sources
The authors report the cases of 3 patients who had depressive episodes after administration of propranolol for medical illnesses. The depressive episodes were severe, occurred in a dose-dependent manner, and promptly remitted when propranolol was discontinued. Physicians' awareness of this complication, especially in cases of patients with a history of
Raymond L. Woosley +2 more
openaire +3 more sources
The Hastings Center Report, 1992
When an anxiety-reducing drug with virtually no side effects is used to enhance performance, is that cheating? Is it drug abuse? Is it an admission of professional weakness? During a series of three performances, a trumpet player in a professional orchestra consistently plays a difficult solo passage flawlessly each time.
openaire +3 more sources
When an anxiety-reducing drug with virtually no side effects is used to enhance performance, is that cheating? Is it drug abuse? Is it an admission of professional weakness? During a series of three performances, a trumpet player in a professional orchestra consistently plays a difficult solo passage flawlessly each time.
openaire +3 more sources
Propranolol and hypertriglyceridemia
Atherosclerosis, 1973Abstract Eight subjects with elevated fasting plasma triglyceride levels and type IV hypertipoproteinemia, who received a 60 g fat meal before and after 2-week treatment with propranolol, showed an enhanced lipemic response to the meal after the treatment.
H. David Friedberg +3 more
openaire +3 more sources
Psychopharmacology, 1976
The morphine blocking and anticonvulsant effects of propranolol were investigated in mice. Three different convulsant procedures (electroshock, pentylenetetrazol and thebaine) were used. In addition, LD50's of morphine after different doses of propranolol were done.
Anatole T. Zuban +2 more
openaire +3 more sources
The morphine blocking and anticonvulsant effects of propranolol were investigated in mice. Three different convulsant procedures (electroshock, pentylenetetrazol and thebaine) were used. In addition, LD50's of morphine after different doses of propranolol were done.
Anatole T. Zuban +2 more
openaire +3 more sources
A Randomized, Controlled Trial of Oral Propranolol for Infantile Hemangioma
, 2015Infantile hemangiomas (IH) affect up to 10% of infants. A rapid proliferative phase is followed by slow spontaneous involution.
M. Chang
semanticscholar +1 more source